Papers: 10.1371/journal.pone.0182115

https://doi.org/10.1371/journal.pone.0182115

Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib

Cited by: 16
Author(s): Astrid Yeo, Li Li, Liling Warren, Jennifer L. Aponte, Dana J. Fraser, Karen S. King, Kelley A. Johansson, Allison Barnes, Colin H. Macphee, Richard Davies, Stephanie L. Chissoe, Elizabeth Tarka, Michelle L. O’Donoghue, Harvey D. White, Lars Wallentin, Dawn Waterworth
Published: about 8 years ago

Software Mentions 1